Home > News > U of I targets treatment of ‘superbug’
December 7th, 2007
U of I targets treatment of ‘superbug’
University of Idaho researchers are working to develop more effective defenses against staphylococcus aureus bacteria and other deadly pathogens.
One of the goals of that effort, the university says, is to create faster and more accurate identification of infection strains resistant to the antibiotic methicillin. MRSA, which stands for methicillin-resistant staphylococcus aureus, is an acronym being used to refer to such so-called "superbug" strains.
Breakthrough detection technologies are already in hand at U of I labs, the university says. Nano-electronic biosensors at the university's Center for Advanced Microelectronics and Biomolecular Research (CAMBR), located in the University of Idaho Research Park, in Post Falls, recently have cut detection time for staph from the industry standard of up to three days down to three hours, researchers claim.
Patent for the Novel Cancer Therapies – Ceramide Nanoliposomes March 4th, 2015
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015
Pens filled with high-tech inks for do-it-yourself sensors March 3rd, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Strength in numbers: Researchers develop the first-ever quantum device that detects and corrects its own errors March 4th, 2015
Energy-generating cloth could replace batteries in wearable devices March 4th, 2015
Experiment and theory unite at last in debate over microbial nanowires: New model and experiments settle debate over metallic-like conductivity of microbial nanowires in bacterium March 4th, 2015
Magnetic vortices in nanodisks reveal information: Researchers from Dresden and Jülich use microwaves to read out information from smallest storage devices March 4th, 2015